Form 4: Encompass Health Director Joan E. Herman Acquires Additional Shares Through Dividend Reinvestment

Sentiment:

SEC Form 4 Filing


Director Joan E. Herman acquired 83 shares of Encompass Health Corp stock through a dividend reinvestment program.

Summary

  • Joan E. Herman, a director at Encompass Health Corp, acquired 83 shares of common stock on January 15, 2025.
  • The shares were acquired through a dividend reinvestment program, where additional restricted stock units (RSUs) are credited to non-employee directors' accounts based on dividend payments.
  • The dividend paid was $0.17 per share, and the closing price of the stock on the dividend payment date was $93.61.
  • The total number of shares owned by Joan E. Herman after the transaction is 46,105.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, which is generally viewed positively as it aligns director interests with shareholders. There are no negative implications.

Positives

  • The acquisition of shares by a director through dividend reinvestment indicates confidence in the company's future.
  • The dividend payment of $0.17 per share is a positive return for shareholders.

Industry Context

This is a routine transaction related to director compensation and dividend reinvestment, which is common practice in publicly traded companies.

Comparison to Industry Standards

  • Dividend reinvestment programs are a common practice among publicly listed companies, including those in the healthcare sector like Encompass Health.
  • Many companies offer similar programs to directors and employees as part of their compensation packages, aligning their interests with shareholders.
  • Companies such as Select Medical Holdings Corporation and HCA Healthcare also have similar compensation structures for their directors.

Stakeholder Impact

  • The transaction has a minor positive impact on shareholders as it demonstrates director confidence in the company.
  • The dividend payment benefits all shareholders.

Key Dates

DateDescription
01/15/2025Date of the stock acquisition and dividend payment.
01/17/2025Date of the signature on the SEC Form 4 filing.

Keywords

Encompass Health, Director, Joan E. Herman, Dividend Reinvestment, Stock Acquisition, Restricted Stock Units, RSUs, Dividend Payment

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.